Back
Sage Therapeutics Stock Predictions
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
23
SAGE
Sage Therapeutics
Last Price:
$6.75
Seasonality Move:
-1.48%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Sage Therapeutics Stock Forecast
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 7.3% based on the past 10 years of stock performance.
-
Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Sage Therapeutics Stock Undervalued?The current Sage Therapeutics [SAGE] share price is $6.56. The Score for SAGE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Sage Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sage Therapeutics has on average historically risen by 7.3% based on the past 10 years of stock performance.
Sage Therapeutics Stock Rating
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics overpriced?
-
Sage Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Sage Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com
52-Week Data
52-Week High:
13.47
52-Week Low:
4.62
Prediction Charts
Market Cap:
410.8M
Price in USD:
6.56
Volume:
997.9K
Beta:
1.29
Technical Analysis
SMA50:
7.52
SMA100:
7.04
SMA200:
7.25
52-Wk Change:
-46.84%
Stock Predictions
-
Is Sage Therapeutics stock public?Yes, Sage Therapeutics is a publicly traded company.
-
What is the Sage Therapeutics stock quote today?The Sage Therapeutics stock price is 6.56 USD today.
-
How to buy Sage Therapeutics stock online?You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 7.55 | 7.68 | 7.73 | 7.43 |
| Apr-23 | 7.75 | 7.62 | 7.89 | 7.61 |
| Apr-24 | 7.63 | 7.79 | 7.79 | 7.56 |
| Apr-25 | 7.73 | 7.79 | 8.02 | 7.73 |
| Apr-28 | 7.77 | 7.77 | 7.86 | 7.69 |
| Apr-29 | 7.78 | 7.60 | 7.82 | 7.57 |
| Apr-30 | 7.50 | 7.29 | 7.64 | 7.23 |
| May-1 | 7.30 | 7.48 | 7.54 | 7.27 |
| May-2 | 7.53 | 7.30 | 7.63 | 7.26 |
| May-5 | 7.28 | 7.17 | 7.36 | 7.14 |
| May-6 | 7.13 | 6.86 | 7.14 | 6.83 |
| May-7 | 7.09 | 6.82 | 7.09 | 6.78 |
| May-8 | 6.97 | 6.71 | 7.00 | 6.70 |
| May-9 | 6.73 | 6.56 | 6.89 | 6.50 |
Sage Therapeutics Earnings
Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sage Therapeutics Forecast Revenue Growth
Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.40 per share, an increase this year of $2.81 per share, and an increase next year of $0.36 per share.
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.